Participants 101 125 3
Hypertension and obesity
Participants 662 698 7
patients with essential hypertension
Participants 724 742 7
healthy volunteers
Participants 808 873 7
85 newly diagnosed patients with untreated essential hypertension
Participants 1030 1124 3
42 patients were randomized into the valsartan group and 43 patients into the amlodipine group
